TOP NEWS: AstraZeneca Drug Fails To Improve Survival In Neptune Trial
(Alliance News) - AstraZeneca PLC on Wednesday said its phase 3 Neptune trial of Imfinzi in combination with tremelimumab did not meet its primary endpoint of improving overall was a randomised, a Read More